» Articles » PMID: 37598276

VHH CDR-H3 Conformation is Determined by VH Germline Usage

Overview
Journal Commun Biol
Specialty Biology
Date 2023 Aug 19
PMID 37598276
Authors
Affiliations
Soon will be listed here.
Abstract

VHHs or nanobodies are single antigen binding domains originating from camelid heavy-chain antibodies. They are used as diagnostic and research tools and in a variety of therapeutic molecules. Analyzing variable domain structures from llama and alpaca we found that VHHs can be classified into two large structural clusters based on their CDR-H3 conformation. Extended CDR-H3 loops protrude into the solvent, whereas kinked CDR-H3 loops fold back onto framework regions. Both major families have distinct properties in terms of their CDR-H3 secondary structure, how their CDR-H3 interacts with the framework region and how they bind to antigens. We show that the CDR-H3 conformation of VHHs correlates with the germline from which the antibodies are derived: IGHV3-3 derived antibodies almost exclusively adopt a kinked CDR-H3 conformation while the CDR-H3 adopts an extended structure in most IGHV3S53 derived antibodies. We do not observe any bias stemming from V(D)J recombination in llama immune repertoires, suggesting that the correlation is the result of selection processes during B-cell development. Our findings demonstrate a previously undescribed impact of germline usage on antigen interaction and contribute to a better understanding on how properties of the antibody framework shape the immune repertoire.

Citing Articles

Distinct types of VHHs in Alpaca.

Wang X, Zhang L, Zhang Y, Li J, Xu W, Zhu W Front Immunol. 2024; 15:1447212.

PMID: 39600702 PMC: 11588638. DOI: 10.3389/fimmu.2024.1447212.


A platform of ADAPTive scaffolds: development of CDR-H3 β-hairpin mimics into covalent inhibitors of the PD1/PDL1 immune checkpoint.

Naylon S, Richaud A, Zhao G, Bui L, Dufresne C, Wu C RSC Chem Biol. 2024; .

PMID: 39552936 PMC: 11562385. DOI: 10.1039/d4cb00174e.


On the humanization of VHHs: Prospective case studies, experimental and computational characterization of structural determinants for functionality.

Fernandez-Quintero M, Guarnera E, Musil D, Pekar L, Sellmann C, Freire F Protein Sci. 2024; 33(11):e5176.

PMID: 39422475 PMC: 11487682. DOI: 10.1002/pro.5176.


Phage display-derived alpaca nanobodies as potential therapeutics for snake envenomation.

Wang W, Chang J, Lee C, Chiang Y, Leu S, Mao Y Appl Environ Microbiol. 2024; 90(8):e0012124.

PMID: 38980046 PMC: 11337809. DOI: 10.1128/aem.00121-24.


De Novo Synthesis and Structural Elucidation of CDR-H3 Loop Mimics.

Zhao G, Richaud A, Williamson R, Feig M, Roche S ACS Chem Biol. 2024; 19(7):1583-1592.

PMID: 38916527 PMC: 11299430. DOI: 10.1021/acschembio.4c00236.


References
1.
De Genst E, Silence K, Decanniere K, Conrath K, Loris R, Kinne J . Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A. 2006; 103(12):4586-91. PMC: 1450215. DOI: 10.1073/pnas.0505379103. View

2.
HAMERS-CASTERMAN C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa E . Naturally occurring antibodies devoid of light chains. Nature. 1993; 363(6428):446-8. DOI: 10.1038/363446a0. View

3.
Govaert J, Pellis M, Deschacht N, Vincke C, Conrath K, Muyldermans S . Dual beneficial effect of interloop disulfide bond for single domain antibody fragments. J Biol Chem. 2011; 287(3):1970-9. PMC: 3283254. DOI: 10.1074/jbc.M111.242818. View

4.
Bond C, Marsters J, Sidhu S . Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries. J Mol Biol. 2003; 332(3):643-55. DOI: 10.1016/s0022-2836(03)00967-7. View

5.
Mitchell L, Colwell L . Comparative analysis of nanobody sequence and structure data. Proteins. 2018; 86(7):697-706. PMC: 6033041. DOI: 10.1002/prot.25497. View